Medicus, Vol. 29 No. 2 COVID-19, 2020.
Review article
Monitoring and Treatment of Renal Transplant Patients During the COVID-19 Pandemic
Nikolina Bašić-Jukić
Ivana Jurić
Vesna Furić-Čunko
Lea Katalinić
Abstract
The COVID-19 pandemic has paralyzed renal transplant programs worldwide, with high mortality rates in renal transplant patients. Faced with an unknown pathogen, we have witnessed numerous treatment attempts that have been more or less effective. Renal transplant recipients are at increased risk for morbidity and mortality from COVID-19 given their chronic immunocompromised state. Additional complications are potential interactions in drugs used for treatment of SARS-CoV-2 and immunosuppressive medications, as well as risk of acute allograft rejection associated with reduction of immunosuppression. The revival of renal transplant programs will require careful assessment of individual risk-to-benefit ratio for each patient, with step-by-step reintroduction of international organ exchange. Further studies are needed to determine optimal treatment of SARS-CoV-2 in renal transplant recipients.
Keywords
renal transplantation,; COVID-19; immunosuppression; SARS-CoV-2
Hrčak ID:
244344
URI
Publication date:
30.9.2020.
Visits: 2.121 *